{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:20:41Z","timestamp":1793283641010,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00198-026-07925-7","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T20:19:07Z","timestamp":1773346747000},"page":"1067-1085","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Predictive value of BMD for hip and other fractures: a meta-analysis to update FRAX"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3129-4326","authenticated-orcid":false,"given":"John A.","family":"Kanis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0177-8140","authenticated-orcid":false,"given":"Eugene V.","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enwu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-2804","authenticated-orcid":false,"given":"Kristina E.","family":"\u00c5kesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0093-333X","authenticated-orcid":false,"given":"Rafael","family":"Azagra-Ledesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie L.","family":"Bager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0827-5303","authenticated-orcid":false,"given":"Charlotte","family":"Beaudart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike A.","family":"Bischoff-Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6174-1951","authenticated-orcid":false,"given":"Emmanuel","family":"Biver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4269-9393","authenticated-orcid":false,"given":"Olivier","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0752-4408","authenticated-orcid":false,"given":"Jane A.","family":"Cauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5278-4527","authenticated-orcid":false,"given":"Jacqueline R.","family":"Center","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Chapurlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3510-0709","authenticated-orcid":false,"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn J.","family":"Crandall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A. P.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3136-0386","authenticated-orcid":false,"given":"Bess","family":"Dawson-Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Diez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa B.","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7162-7471","authenticated-orcid":false,"given":"John A.","family":"Eisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra J. M.","family":"Elders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7490-258X","authenticated-orcid":false,"given":"Yuki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeko","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus-Christian","family":"Gl\u00fcer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5317-2848","authenticated-orcid":false,"given":"Inbal","family":"Goldshtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goltzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilmundur","family":"Gudnason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Hans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9992-8663","authenticated-orcid":false,"given":"Mari","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-7189","authenticated-orcid":false,"given":"Rosemary J.","family":"Hollick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Huisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Iki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Ish-Shalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0616-5928","authenticated-orcid":false,"given":"Magnus K.","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Khosla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas P.","family":"Kiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5674-6341","authenticated-orcid":false,"given":"Woon-Puay","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fjorda","family":"Koromani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8094-1411","authenticated-orcid":false,"given":"Mark A.","family":"Kotowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4245-8186","authenticated-orcid":false,"given":"Heikki","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9253-3549","authenticated-orcid":false,"given":"Timothy","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5296-6673","authenticated-orcid":false,"given":"Arnulf","family":"Langhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Lippuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Mellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Merlijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence W.","family":"O\u00b4Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3543-1807","authenticated-orcid":false,"given":"Barbara","family":"Obermayer-Pietsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claes","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8520-7355","authenticated-orcid":false,"given":"Eric S.","family":"Orwoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8968-4714","authenticated-orcid":false,"given":"Julie A.","family":"Pasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rivadeneira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit","family":"Schei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Shiroma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Siggeirsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor M.","family":"Simonsick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Sornay-Rendu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6268-8117","authenticated-orcid":false,"given":"Reijo","family":"Sund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4168-6697","authenticated-orcid":false,"given":"Pawel","family":"Szulc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Torgerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0870-0795","authenticated-orcid":false,"given":"Natasja M.","family":"van Schoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjeerd P.","family":"van Staa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8414-4842","authenticated-orcid":false,"given":"Nicole C.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9206-4658","authenticated-orcid":false,"given":"Noriko","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carola","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4888-0927","authenticated-orcid":false,"given":"Marta","family":"Zwart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-2512","authenticated-orcid":false,"given":"Nicholas C.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Lorentzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1056-1691","authenticated-orcid":false,"given":"William D.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"7925_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/0002-9343(93)90218-E","volume":"94","author":"Anonymous","year":"1993","unstructured":"Anonymous (1993) Consensus development conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646\u2013650","journal-title":"Am J Med"},{"key":"7925_CR2","volume-title":"Report of a WHO study group WHO Technical Report Series 843","author":"World Health Organization","year":"1994","unstructured":"World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group WHO Technical Report Series 843. World Health Organization, Geneva"},{"key":"7925_CR3","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"JA Kanis","year":"1994","unstructured":"Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137\u20131141","journal-title":"J Bone Miner Res"},{"issue":"1","key":"7925_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00223-024-01336-8","volume":"116","author":"JA Kanis","year":"2025","unstructured":"Kanis JA, Johansson H, Lorentzon M, Harvey NC, McCloskey EV (2025) Conflating the operational definition of osteoporosis with intervention thresholds. Calcif Tissue Int 116(1):22. https:\/\/doi.org\/10.1007\/s00223-024-01336-8","journal-title":"Calcif Tissue Int"},{"key":"7925_CR5","volume-title":"Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis","author":"Food and Drug Administration","year":"1994","unstructured":"Food and Drug Administration (1994) Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis. Division of Metabolism and Endocrine Drug Products, Food and Drug Administration, Rockville, MD"},{"key":"7925_CR6","unstructured":"Committee for Medicinal Products for Human Use (CHMP) (2006) Guideline on the evaluation of medicinal products in the treatment of primary osteoporosis. Ref CPMP\/EWP\/552\/95Rev.2. London, CHMP. Nov 2006"},{"key":"7925_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-005-1984-3","volume":"17","author":"JY Reginster","year":"2006","unstructured":"Reginster JY, Abadie E, Delmas P, Rizzoli R, Dere W, der Auwera P et al (2006) Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men. Osteoporos Int 17:1\u20137","journal-title":"Osteoporos Int"},{"key":"7925_CR8","unstructured":"Pharmaceuticals and Medical Devices Agency, Japan Ministry of Health (2022). https:\/\/ ss. pmda. go. jp\/ en_ all\/ search. x?q= osteoporos is& ie= utf8& cat= 0& pagem ax= 10& imgsi ze= 1& pdf= ok&zoom= 1& sugge st= 1& couns el= 1& ref= www. pmda. go. jp& pid=Fp8oj 1XtsO nvzmF 1SMqO wQ.. & qid= YlyMt LtewU XjdTr 9eaLGkxC7j 2s5Iq GL& page=2. Accessed June 16 2025"},{"key":"7925_CR9","volume-title":"Guidelines for preclinical evaluation and clinical trials in osteoporosis","author":"World Health Organization","year":"1998","unstructured":"World Health Organization (1998) Guidelines for preclinical evaluation and clinical trials in osteoporosis. WHO, Geneva"},{"key":"7925_CR10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","volume":"312","author":"D Marshall","year":"1996","unstructured":"Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254\u20131259","journal-title":"BMJ"},{"issue":"7","key":"7925_CR11","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1359\/JBMR.050304","volume":"20","author":"O Johnell","year":"2005","unstructured":"Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P et al (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20(7):1185\u20131194","journal-title":"J Bone Miner Res"},{"key":"7925_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","volume":"18","author":"JA Kanis","year":"2007","unstructured":"Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033\u20131046","journal-title":"Osteoporos Int"},{"key":"7925_CR13","unstructured":"Kanis JA on behalf of the World Health Organization Scientific Group (2007) Assessment of osteoporosis at the primary health care level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK. Available at: https:\/\/www.fraxplus.org\/sites\/frax\/files\/pdf\/WHO_Technical_Report.pdf Accessed 3 November 2025"},{"issue":"8","key":"7925_CR14","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jbmr.1956","volume":"28","author":"KH Rubin","year":"2013","unstructured":"Rubin KH, Friis-Holmberg T, Hermann AP, Abrahamsen B, Brixen K (2013) Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. J Bone Miner Res 28(8):1701\u20131717. https:\/\/doi.org\/10.1002\/jbmr.1956","journal-title":"J Bone Miner Res"},{"key":"7925_CR15","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1007\/s40618-023-02082-8","volume":"46","author":"G Adami","year":"2023","unstructured":"Adami G, Biffi A, Porcu G, Ronco R, Alvaro R, Bogini R et al (2023) A systematic review on the performance of fracture risk assessment tools: FRAX, DeFRA, FRA-HS. J Endocrinol Invest 46:2287\u20132297","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"7925_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1148\/radiol.2411051290","volume":"241","author":"MJ Henry","year":"2006","unstructured":"Henry MJ, Pasco JA, Sanders KM, Nicholson GC, Kotowicz MA (2006) Fracture risk (FRISK) score: Geelong osteoporosis study. Radiology 241(1):190\u2013196","journal-title":"Radiology"},{"issue":"11","key":"7925_CR17","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-207907","volume":"74","author":"A Marques","year":"2015","unstructured":"Marques A, Ferreira RJ, Santos E, Loza E, Carmona L, da Silva JA (2015) The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis. Ann Rheum Dis 74(11):1958\u201367","journal-title":"Ann Rheum Dis"},{"key":"7925_CR18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jocd.2017.06.022","volume":"20","author":"JA Kanis","year":"2017","unstructured":"Kanis JA, Harvey NC, Johansson H, Od\u00e9n A, McCloskey EV, Leslie WD (2017) Overview of fracture prediction tools. J Clin Densitom 20:360\u2013367","journal-title":"J Clin Densitom"},{"key":"7925_CR19","unstructured":"Kanis JA, Johansson H, Oden A, Cooper C, McCloskey EV, the Epidemiology and Quality of Life Working Group of IOF (2013) Worldwide uptake of FRAX. Arch Osteoporos 8:166. https:\/\/doi.org\/10.1007\/s11657-013- 0166-8"},{"key":"7925_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-016-0278-z","volume":"11","author":"JA Kanis","year":"2016","unstructured":"Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV, The Advisory Board of the National Osteoporosis Guideline Group (2016) A systematic review of intervention thresholds based on FRAX. A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11:25. https:\/\/doi.org\/10.1007\/s11657-016-0278-z","journal-title":"Arch Osteoporos"},{"key":"7925_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ III, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42:467\u2013475","journal-title":"Bone"},{"issue":"3","key":"7925_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00198-023-07012-1","volume":"35","author":"L Vandenput","year":"2024","unstructured":"Vandenput L, Johansson H, McCloskey EV, Liu E, \u00c5kesson KE, Anderson FA et al (2024) A meta-analysis of previous falls and subsequent fracture risk. Osteoporos Int 35(3):469\u2013494","journal-title":"Osteoporos Int"},{"key":"7925_CR23","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s00198-023-06870-z","volume":"34","author":"JA Kanis","year":"2023","unstructured":"Kanis JA, Johansson H, McCloskey EV, Liu E, \u00c5kesson KE, Anderson FA et al (2023) Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX. Osteoporos Int 34:2027\u20132045","journal-title":"Osteoporos Int"},{"issue":"4","key":"7925_CR24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00198-025-07397-1","volume":"36","author":"JA Kanis","year":"2025","unstructured":"Kanis JA, Schini M, Vandenput L, \u00c5kesson KE, Anderson FA, Azagra R et al (2025) A meta-analysis of rheumatoid arthritis and subsequent fracture risk: a meta-analysis to update FRAX. Osteoporos Int 36(4):653\u2013671. https:\/\/doi.org\/10.1007\/s00198-025-07397-1","journal-title":"Osteoporos Int"},{"issue":"10","key":"7925_CR25","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/jbmr\/zjaf091","volume":"40","author":"NC Harvey","year":"2025","unstructured":"Harvey NC, Johansson H, McCloskey EV, Liu E, Kristina E \u00c5kesson KE et al (2025) Body mass index and subsequent fracture risk: a meta-analysis to update FRAX. J Bone Miner Res 40(10):1144\u20131155. https:\/\/doi.org\/10.1093\/jbmr\/zjaf091","journal-title":"J Bone Miner Res"},{"issue":"9","key":"7925_CR26","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s00198-025-07607-w","volume":"36","author":"EV McCloskey","year":"2025","unstructured":"McCloskey EV, Johansson H, Liu E, \u00c5kesson KE, Anderson FA, Azagra-Ledesma R et al (2025) Family history of fracture and fracture risk: a meta-analysis to update the FRAX\u00ae risk assessment tool. Osteoporos Int 36(9):1725\u20131741. https:\/\/doi.org\/10.1007\/s00198-025-07607-w","journal-title":"Osteoporos Int"},{"key":"7925_CR27","unstructured":"Schini M, Johansson H, Harvey NC, Lorentzon M, Liu E, Vandenput L at al (2026) A meta-analysis on smoking and fracture risk. Osteoporos Int in press"},{"key":"7925_CR28","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00198-022-06435-6","volume":"33","author":"L Vandenput","year":"2022","unstructured":"Vandenput L, Johansson H, McCloskey EV, Liu E, Akesson KE, Anderson FA et al (2022) Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan. Osteoporos Int 33:2103\u20132136","journal-title":"Osteoporos Int"},{"key":"7925_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s001980170112","volume":"12","author":"JA Kanis","year":"2001","unstructured":"Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417\u2013427","journal-title":"Osteoporos Int"},{"key":"7925_CR30","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s001980050093","volume":"8","author":"AC Looker","year":"1998","unstructured":"Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr., Lindsay R (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468\u2013489","journal-title":"Osteoporos Int"},{"key":"7925_CR31","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s001980170087","volume":"12","author":"Y Lu","year":"2001","unstructured":"Lu Y, Fuerst T, Hui S, Genant HK (2001) Standardization of bone mineral density at femoral neck, trochanter and Ward\u2019s triangle. Osteoporos Int 12:438\u2013444","journal-title":"Osteoporos Int"},{"key":"7925_CR32","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1007\/s00198-013-2413-7","volume":"24","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, Adachi JD, Cooper C, Clark P, Cummings SR, Diaz-Curiel M et al (2013) Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF. Osteoporos Int 24:2763\u20134. https:\/\/doi.org\/10.1007\/s00198-013-2413-7","journal-title":"Osteoporos Int"},{"key":"7925_CR33","unstructured":"Breslow NE, Day NE (1987) Statistical methods in cancer research. Volume II--the design and analysis of cohort studies. IARC Sci Publ 1\u2013406."},{"key":"7925_CR34","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1210\/jc.2015-3951","volume":"101","author":"K Albertsson-Wikland","year":"2016","unstructured":"Albertsson-Wikland K, Martensson A, Savendahl L, Niklasson A, Bang P, Dahlgren J et al (2016) Mortality is not increased in recombinant human growth hormone-treated patients when adjusting for birth characteristics. J Clin Endocrinol Metab 101:2149\u20132159","journal-title":"J Clin Endocrinol Metab"},{"key":"7925_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"key":"7925_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-13-204","volume":"13","author":"R Azagra","year":"2012","unstructured":"Azagra R, Roca G, Encabo G, Aguy\u00e9 A, Zwart M, G\u00fcell S, Puchol N et al (2012) FRAX\u00ae tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort. BMC Musculoskelet Disord 13:204. https:\/\/doi.org\/10.1186\/1471-2474-13-204","journal-title":"BMC Musculoskelet Disord"},{"key":"7925_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-016-1096-6","volume":"17","author":"R Azagra","year":"2016","unstructured":"Azagra R, Zwart M, Encabo G, Aguy\u00e9 A, Martin-S\u00e1nchez JC, Puchol-Ruiz N et al (2016) Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women. BMC Musculoskelet Disord 17:1\u201310. https:\/\/doi.org\/10.1186\/s12891-016-1096-6","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"7925_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10532","volume":"5","author":"F Baleanu","year":"2021","unstructured":"Baleanu F, Iconaru L, Charles A, Kinnard V, Fils J-F, Moreau M et al (2021) Independent external validation of FRAX and Garvan fracture risk calculators: a sub-study of the FRISBEE cohort. J BMR Plus 5(9):e10532. https:\/\/doi.org\/10.1002\/jbm4.10532","journal-title":"J BMR Plus"},{"key":"7925_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083436","author":"K Briot","year":"2013","unstructured":"Briot K, Paternotte S, Kolta S, Eastell R, Felsenberg D, Reid DM et al (2013) FRAX\u00ae: prediction of major osteoporotic fractures in women from the general population: the OPUS study. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0083436","journal-title":"PLoS One"},{"issue":"9","key":"7925_CR40","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/jbmr.4638","volume":"37","author":"M Farzi","year":"2022","unstructured":"Farzi M, Pozo JM, McCloskey E, Eastell R, Harvey NC, Frangi AF et al (2022) Quantitating age-related BMD textural variation from DXA region-free-analysis: a study of hip fracture prediction in three cohorts. J Bone Miner Res 37(9):1679\u201388. https:\/\/doi.org\/10.1002\/jbmr.4638","journal-title":"J Bone Miner Res"},{"issue":"3","key":"7925_CR41","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00198-010-1465-1","volume":"22","author":"LA Fraser","year":"2011","unstructured":"Fraser LA, Langsetmo L, Berger C, Ioannidis G, Goltzman D, Adachi JD et al (2011) Fracture prediction and calibration of a Canadian FRAX\u00ae tool: a population-based report from CaMos. Osteoporos Int 22(3):829\u201337. https:\/\/doi.org\/10.1007\/s00198-010-1465-1","journal-title":"Osteoporos Int"},{"key":"7925_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-017-0389-1","author":"ML Gourlay","year":"2017","unstructured":"Gourlay ML, Ritter VS, Fine JP, Overman RA, Schousboe JT, Cawthon PM et al (2017) Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS study. Arch Osteoporos. https:\/\/doi.org\/10.1007\/s11657-017-0389-1","journal-title":"Arch Osteoporos"},{"issue":"3","key":"7925_CR43","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jocd.2019.02.001","volume":"22","author":"WD Leslie","year":"2019","unstructured":"Leslie WD, Luo Y, Yang S, Goertzen AL, Ahmed S, Delubac I et al (2019) Fracture risk indices from DXA-based finite element analysis predict incident fractures independently from FRAX: the Manitoba BMD registry. J Clin Densitom 22(3):338\u201345. https:\/\/doi.org\/10.1016\/j.jocd.2019.02.001","journal-title":"J Clin Densitom"},{"key":"7925_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000509","author":"A Marques","year":"2017","unstructured":"Marques A, Lucas R, Sim\u00f5es E, Verstappen SMM, Jacobs JWG, Da Silva JAP (2017) Do we need bone mineral density to estimate osteoporotic fracture risk? A 10-year prospective multicentre validation study. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2017-000509","journal-title":"RMD Open"},{"issue":"4","key":"7925_CR45","doi-asserted-by":"publisher","first-page":"646","DOI":"10.2215\/CJN.06040614","volume":"10","author":"KL Naylor","year":"2015","unstructured":"Naylor KL, Garg AX, Zou G, Langsetmo L, Leslie WD, Fraser L-A et al (2015) Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol 10(4):646\u201353. https:\/\/doi.org\/10.2215\/CJN.06040614","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"7925_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00223-014-9860-9","volume":"95","author":"R Sund","year":"2014","unstructured":"Sund R, Honkanen R, Johansson H, Od\u00e9n A, McCloskey E, Kanis J et al (2014) Evaluation of the FRAX model for hip fracture predictions in the population-based Kuopio Osteoporosis Risk Factor and Prevention study (OSTPRE). Calcif Tissue Int 95(1):39\u201345. https:\/\/doi.org\/10.1007\/s00223-014-9860-9","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"7925_CR47","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1007\/s00198-011-1537-x","volume":"22","author":"J Tamaki","year":"2011","unstructured":"Tamaki J, Iki M, Kadowaki E, Sato Y, Kajita E, Kagamimori S et al (2011) Fracture risk prediction using FRAX\u00ae: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) cohort study. Osteoporos Int 22(12):3037\u201345","journal-title":"Osteoporos Int"},{"issue":"6","key":"7925_CR48","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.bone.2010.08.019","volume":"47","author":"S Tanaka","year":"2010","unstructured":"Tanaka S, Yoshimura N, Kuroda T, Hosoi T, Saito M, Shiraki M (2010) The fracture and immobilization score (FRISC) for risk assessment of osteoporotic fracture and immobilization in postmenopausal women- -a joint analysis of the Nagano, Miyama, and Taiji cohorts. Bone 47(6):1064\u201370. https:\/\/doi.org\/10.1016\/j.bone.2010.08.019","journal-title":"Bone"},{"key":"7925_CR49","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s001980050061","volume":"8","author":"AM Schott","year":"1998","unstructured":"Schott AM, Cormier C, Hans D, Favier F, Hausherr E, Dargent-Molina P, Delmas P, Ribot C, Sebert JL, Breart G, Meunier PJ (1998) How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS prospective study. Osteoporos Int 8:247\u2013254","journal-title":"Osteoporos Int"},{"key":"7925_CR50","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S8756-3282(00)00238-6","volume":"26","author":"JA Kanis","year":"2001","unstructured":"Kanis JA, Johnell O, Od\u00e9n A, J\u00f6nsson B, De Laet C, Dawson A (2001) Prediction of fracture from low bone mineral density measurements overestimates risk. Bone 26:387\u2013391","journal-title":"Bone"},{"issue":"10","key":"7925_CR51","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/archinte.164.10.1108","volume":"164","author":"ES Siris","year":"2004","unstructured":"Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE et al (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164(10):1108\u201312. https:\/\/doi.org\/10.1001\/archinte.164.10.1108","journal-title":"Arch Intern Med"},{"key":"7925_CR52","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1359\/jbmr.1998.13.10.1587","volume":"13","author":"CEDH De Laet","year":"1998","unstructured":"De Laet CEDH, Van Hout BA, Burger H, Hofman A, Weel AEAM, Pols HAP (1998) Hip fracture prediction in elderly men and women: validation of the Rotterdam study. J Bone Miner Res 13:1587\u20131593","journal-title":"J Bone Miner Res"},{"key":"7925_CR53","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/bmj.315.7102.221","volume":"315","author":"CEDH De Laet","year":"1997","unstructured":"De Laet CEDH, Van Hout BA, Burger H, Hofman A, Pols HAP (1997) Bone density and risk of hip fracture in men and women: cross sectional analysis. BMJ 315:221\u2013225","journal-title":"BMJ"},{"issue":"9","key":"7925_CR54","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00198-025-07628-5","volume":"36","author":"NC Harvey","year":"2025","unstructured":"Harvey NC, Al-Daghri N, Beaudart C, Brandi ML, Burlet N, Campusano C et al (2025) Barriers and solutions for global access to osteoporosis management: a position paper from the International Osteoporosis Foundation. Osteoporos Int 36(9):1495\u20131507. https:\/\/doi.org\/10.1007\/s00198-025-07628-5","journal-title":"Osteoporos Int"},{"issue":"10","key":"7925_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100776","volume":"3","author":"M Nethander","year":"2022","unstructured":"Nethander M, Coward E, Reimann E, Grahnemo L, Gabrielsen ME, Wibom C (2022) Assessment of the genetic and clinical determinants of hip fracture risk: genome-wide association and Mendelian randomization study. Cell Rep Med 3(10):100776. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100776","journal-title":"Cell Rep Med"},{"key":"7925_CR56","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/jbmr.1582","volume":"27","author":"WD Leslie","year":"2012","unstructured":"Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis J (2012) Does osteoporosis therapy invalidate FRAX for fracture prediction? J Bone Miner Res 27:1243\u20131251","journal-title":"J Bone Miner Res"}],"updated-by":[{"DOI":"10.1007\/s00198-026-07969-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000}}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-07925-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-07925-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-07925-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:03:48Z","timestamp":1788865428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-026-07925-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["7925"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-07925-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00198-026-07969-9","URL":"https:\/\/doi.org\/10.1007\/s00198-026-07969-9","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All individual cohorts with candidate risk factors available have been approved by their local ethics committees, and informed consent has been obtained from all study participants. General ethics approval for the use of these cohorts is also given by the University of Sheffield. Participant data will be stored in coded, de-identified form. Only summary statistics and aggregate data will be published, not allowing for identification of individual study participants.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JA Kanis led the team that developed FRAX as director of the WHO Collaborating Centre for Metabolic Bone Diseases. EV McCloskey, WD Leslie, M Lorentzon, NC Harvey, E Liu, L Vandenput, and H Johansson are members of the FRAX team. JA Kanis, NC Harvey, and EV McCloskey are members of the advisory body to the National Osteoporosis Guideline Group. JA Kanis reports no additional competing interests. EV McCloskey has received consultancy\/lecture fees\/grant funding\/honoraria from AgNovos, Amgen, AstraZeneca, Consilient Healthcare, Fresenius Kabi, Gilead, GSK, Hologic, Internis, Lilly, Merck, Novartis, Pfizer, Radius Health, Redx Oncology, Roche, Sanofi Aventis, UCB, ViiV, Warner Chilcott, and I3 Innovus. KE \u00c5kesson has no financial interest related to FRAX; chaired the National SALAR Group for Person-Centered Care Pathway Osteoporosis. FA Anderson led the team that developed GLOW, while director of the Center for Outcomes Research at the University of Massachusetts Medical School; he has no financial interest in FRAX. Azagra-Ledesma has received funding for research from Instituto Carlos III of the Spanish Ministry of Health, IDIAP Jordi Gol of the Catalan Government and from Scientific Societies SEMFYC and SEIOMM. CL Bager is employed at Nordic Bioscience and owns stock in Nordic Bioscience. She declares no competing interests in relation to this work. HA Bischoff-Ferrari has no financial interest in FRAX. For the DO-HEALTH trial cohort, Prof. Bischoff-Ferrari reports independent and investigator-initiated grants from the European Commission Framework 7 Research Program, from the University of Zurich, from NESTEC, from Pfizer Consumer Healthcare, from Streuli Pharma, plus non-financial support from DNP. For the study cohort extension, she reports independent and investigator-initiated grants from Pfizer and from Vifor. Further, Prof. Bischoff-Ferrari reports non-financial support from Roche Diagnostics and personal fees from Wild, Sandoz, Pfizer, Vifor, Mylan, Roche, Meda Pharma, outside the submitted work with regard to speaker fees and travel fees. JR Center has received honoraria for speaking at educational meetings and for advisory boards from Amgen and honoraria for an advisory board from Bayer, all unrelated to this work. R Chapurlat has no financial interest in FRAX. He has received grant funding from Amgen, UCB, Chugai, MSD, Mylan, and Medac. He has received honoraria from Amgen, UCB, Chugai, Galapagos, Biocon, Abbvie, Haoma Medica, Pfizer, Amolyt, MSD, Lilly, BMS, Novartis, Arrow, PKMed, Kyowa-Kirin, Nova in silico, and Sanofi. C Christiansen owns stock in Nordic Bioscience. He declares no competing interests in relation to this work. C Cooper reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda, and UCB. B Dawson-Hughes has research funding from the National Institutes of Health and the USDA Agricultural Research Service; she declares no competing interests in relation to this work. A Diez-Perez reports personal fees from Amgen, Lilly, Theramex and grants from Instituto Carlos III and owns shares of Active Life Scientific, all outside the submitted work. JA Eisman declares consulting and research support from Actavis, Amgen, Aspen, Lilly, Merck Sharp and Dohme, Novartis, Sanofi-Aventis, Servier, and Theramex. PJM Elders has no financial interest in FRAX. PJM Elders reports support for the SOS study by Stichting Achmea Gezondheidszorg, Achmea and VGZ zorgverzekeraar. Additional support was given by the stichting Artsenlaboratorium en Trombosedienst. Outside the submitted work, she did receive independent investigator driven grants by Zonmw, the Netherlands, de Hartstichting, the Netherlands, the European foundation for the study of Diabetes, Amgen the Netherlands, TEVA, the Netherlands, and Takeda, the Netherlands. Claus-C. Gl\u00fcer reports honoraria and research support from AgNovos, Amgen, Osteolabs, and UCB unrelated to this work. D Goltzman has received funding for the Canadian Multicentre Osteoporosis Study (CaMos) from the Canadian Institutes for Health Research (CIHR). NC Harvey has received consultancy\/lecture fees\/honoraria\/grant funding from Alliance for Better Bone Health, Amgen, MSD, Eli Lilly, Radius Health, Servier, Shire, UCB, Consilient Healthcare, Kyowa Kirin, Theramex, and Internis Pharma. S Ish Shalom received consultancy fees from RAFA pharmaceuticals (importer of abaloparatide). DP Kiel has no financial interest in FRAX but has received support for his work in the Framingham Study over the past 30\u00a0years by the National Institutes of Health, Astra Zeneca, Merck, Amgen, and Radius Health. MA Kotowicz has received funding from the National Health and Medical Research Council (NHMRC) Australia, and the Medical Research Future Fund (MRFF) Australia. He has served on advisory boards for Amgen Australia, Novartic, and Eli Lilly\u2014all unrelated to this work and was the Director of the Geelong Bone Densitometry Service until 2022. A Langhammer is PI of the HUNT Lung and Osteoporosis project, the project got some funding from AstraZeneca for data collection. He has received lecture or consultant fees from AstraZeneca, GSK, Boehringer Ingelheim, and Diagnostica. No funding related to this study. M Lorentzon has received lecture fees from Amgen, Lilly, Meda, Gedeon Richter, Medison Pharma, UCB Pharma and consulting fees from Amgen, Radius Health, UCB Pharma, Medac AB, Parexel International, all outside the presented work. EV McCloskey has received consultancy\/lecture fees\/grant funding\/honoraria from AgNovos, Amgen, AstraZeneca, Consilient Healthcare, Fresenius Kabi, Gilead, GSK, Hologic, Internis, Lilly, Merck, Novartis, Pfizer, Radius Health, Redx Oncology, Roche, Sanofi Aventis, UCB, ViiV, Warner Chilcott, and I3 Innovus. C Ohlsson is listed as a coinventor on two patent applications regarding probiotics in osteoporosis treatment. TW O\u2019Neill reports honoraria from UCB unrelated to this work. ES Orwoll reports consulting fees from Angios, Biocon, Radius, and Bayer. JA Pasco has received funding from the National Health and Medical Research Council (NHMRC) Australia, and the Medical Research Future Fund (MRFF) Australia, and Amgen, all unrelated to this work. KMA Swart is an employee of the PHARMO Institute for Drug Outcomes Research. This independent research institute performs financially supported studies for government and related healthcare authorities and several pharmaceutical companies. NC Wright sits on the Board of Trustee of the US Bone Health and Osteoporosis Foundation. MC Zillikens reports honoraria for lectures and consulting from Amgen and Kyowa Kirin and research support from Kyowa Kirin to her institution, unrelated to this work. M Zwart has received research funding from national societies (SEMFYC and SEIOMM).","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review does not contain any original studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","label":"Human and animal rights","group":{"name":"EthicsHeading","label":"Declarations"}}]}}